Authors:
BONNER JA
FRYTAK S
SLOAN J
FOOTE RL
MARKS RS
CREAGAN ET
RICHARDSON RL
DESCHAMPS C
Citation: Ja. Bonner et al., DAILY ETOPOSIDE AND CISPLATIN DURING THORACIC RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 312-312
Authors:
RAJKUMAR SV
FRYTAK S
RUBIN J
CAMORIANO JK
FITCH TR
Citation: Sv. Rajkumar et al., COMBINATION CHEMOTHERAPY WITH CISPLATIN, CARBOPLATIN, AND ETOPOSIDE IN ADVANCED MALIGNANCY - A PHASE-I TRIAL, American journal of clinical oncology, 20(5), 1997, pp. 500-504
Citation: R. Kochhar et al., SURVIVAL OF PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER WHO HAVE ONLY BRAIN METASTASES AT INITIAL DIAGNOSIS, American journal of clinical oncology, 20(2), 1997, pp. 125-127
Authors:
SAWYER TE
BONNER JA
GOULD PM
FOOTE RL
DESCHAMPS C
TRASTEK VF
PAIROLERO PC
ALLEN MS
SHAW EG
MARKS RS
FRYTAK S
LANGE CM
LI HZ
Citation: Te. Sawyer et al., THE IMPACT OF SURGICAL ADJUVANT THORACIC RADIATION-THERAPY FOR PATIENTS WITH NONSMALL CELL LUNG-CARCINOMA WITH IPSILATERAL MEDIASTINAL LYMPH-NODE INVOLVEMENT, Cancer, 80(8), 1997, pp. 1399-1408
Citation: E. Galanis et al., EXTRAPULMONARY SMALL-CELL CARCINOMA - EPIDEMIOLOGY AND RESPONSE TO TREATMENT, Journal of investigative medicine, 44(3), 1996, pp. 249-249
Authors:
SHAW EG
FRYTAK S
EAGAN RT
RICHARDSON RL
CREAGAN ET
JETT JR
FOOTE RL
SU JQ
SCHAID DJ
LEE RE
Citation: Eg. Shaw et al., ETOPOSIDE-CISPLATIN AND THORACIC RADIATION-THERAPY SALVAGE OF INCOMPLETE RESPONDERS TO A NONCISPLATIN INDUCTION REGIMEN FOR LIMITED AND EXTENSIVE SMALL-CELL CARCINOMA OF THE LUNG, American journal of clinical oncology, 19(2), 1996, pp. 154-158
Authors:
FRYTAK S
SHAW EG
JETT JR
RICHARDSON RL
FOOTE RL
CREAGAN ET
EAGAN RT
SU JQ
Citation: S. Frytak et al., INFUSION CISPLATIN CHEMOTHERAPY AND HYPERFRACTIONATED THORACIC RADIOTHERAPY FOR SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 19(2), 1996, pp. 193-198
Authors:
BONNER JA
EAGAN RT
LIENGSWANGWONG V
FRYTAK S
SHAW EG
EVANS RG
CREAGAN ET
RICHARDSON RL
Citation: Ja. Bonner et al., LONG-TERM RESULTS OF A PHASE I II STUDY OF AGGRESSIVE CHEMOTHERAPY AND SEQUENTIAL UPPER AND LOWER HEMIBODY RADIATION FOR PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER/, Cancer, 76(3), 1995, pp. 406-412
Authors:
LIENGSWANGWONG V
BONNER JA
SHAW EG
FOOTE RL
FRYTAK S
EAGAN RT
JETT JR
RICHARDSON RL
CREAGAN ET
SU JQ
Citation: V. Liengswangwong et al., LIMITED-STAGE SMALL-CELL LUNG-CANCER - PATTERNS OF INTRATHORACIC RECURRENCE AND THE IMPLICATIONS FOR THORACIC RADIOTHERAPY, Journal of clinical oncology, 12(3), 1994, pp. 496-502
Authors:
CALL TG
CREAGAN ET
FRYTAK S
BUCKNER JC
VANHAELSTPISANI C
HOMBURGER HA
KATZMANN JA
Citation: Tg. Call et al., PHASE-I TRIAL OF COMBINED RECOMBINANT INTERLEUKIN-2 WITH LEVAMISOLE IN PATIENTS WITH ADVANCED MALIGNANT DISEASE, American journal of clinical oncology, 17(4), 1994, pp. 344-347
Authors:
EDMONSON JH
RYAN LM
BLUM RH
BROOKS JSJ
SHIRAKI M
FRYTAK S
PARKINSON DR
Citation: Jh. Edmonson et al., RANDOMIZED COMPARISON OF DOXORUBICIN ALONE VERSUS IFOSFAMIDE PLUS DOXORUBICIN OR MITOMYCIN, DOXORUBICIN, AND CISPLATIN AGAINST ADVANCED SOFT-TISSUE SARCOMAS, Journal of clinical oncology, 11(7), 1993, pp. 1269-1275
Authors:
LIENGSWANGWONG V
BONNER JA
SHAW EG
FOOTE RL
FRYTAK S
RICHARDSON RL
EAGAN RT
SU JQ
Citation: V. Liengswangwong et al., LIMITED-STAGE SMALL-CELL LUNG-CANCER - PATTERNS OF INTRATHORACIC RECURRENCE AND THE IMPLICATIONS FOR THORACIC RADIOTHERAPY, International journal of radiation oncology, biology, physics, 27, 1993, pp. 188-189